Targeted News Service logo

-- Preview Email Newsletter
Journals Media Newsletter for 2026-01-31 ( 8 items )  
BMJ Group: Major US Tobacco Brands Flouting Platform + Federal Policies to Restrict Young People's Access to Their Content on Instagram (10)
LONDON, England, Jan. 29 (TNSjou) -- BMJ Group issued the following news release about their journal "Tobacco Control": * * * Major US tobacco brands flouting platform + federal policies to restrict young people's access to their content on Instagram Violations include lax/missing age verification, sponsorship disclosure, and health warnings * Leading US tobacco brands are flouting platform and federal marketing policies designed to restrict young people's access to their content on the pop more PR

Center for European Policy Analysis Issues Commentary: Europe Should Exploit Georgia's Regime Ructions (10)
WASHINGTON, Jan. 31 -- The Center for European Policy Analysis issued the following commentary on Jan. 30, 2026: * * * Europe Should Exploit Georgia's Regime Ructions Purges and recriminations at the top of Georgia's governing party have created an opportunity for Europe to support democracy. By Irina Arabidze The latest fracture in Georgia's elite came on January 12, when former primed minister Irakli Garibashvili was jailed for five years after pleading guilty to money-laundering. Garibas more PR

Center for European Policy Analysis Issues Commentary: Internet, Switched Off (10)
WASHINGTON, Jan. 31 -- The Center for European Policy Analysis issued the following commentary on Jan. 30, 2026: * * * The Internet, Switched Off Iran's shutdown underlines how governments around the globe are restricting internet access. By Anda Bologa When Iranians revolted, their government cut them off from the world. Mobile networks degraded first. Fixed-line disruptions followed. Instead of cutting cables, the authorities interfered with routing and key protocols. As Iran shut down t more PR

Federal Reserve: Policy Issues in the 119th Congress Topic of CRS Report (Part 1 of 4) (10)
WASHINGTON, Jan. 30 (TNSLrpt) -- The Congressional Research Service issued the following report (No. R48390) on Jan. 14, 2026, entitled "Federal Reserve: Policy Issues in the 119th Congress" by macroeconomic policy specialist Marc Labonte. Here are excerpts: * * * SUMMARY The responsibilities of the Federal Reserve (Fed) fall into four main categories: monetary policy, regulation of certain banks and other financial firms, provision and oversight of certain interbank payment systems, and len more PR

Federal Reserve: Policy Issues in the 119th Congress Topic of CRS Report (Part 3 of 4) (10)
WASHINGTON, Jan. 30 (TNSLrpt) -- The Congressional Research Service issued the following report (No. R48390) on Jan. 14, 2026, entitled "Federal Reserve - Policy Issues in the 119th Congress:" (Continued from Part 2 of 4) * * * Bank Regulation The Fed regulates bank holding companies (BHCs) and thrift holding companies - parent companies that own most large and small depositories - to try to ensure that they do not pose safety and soundness risks to their depositories and for other regulator more PR

Finerenone Recommended for the Treatment of Patients With Heart Failure With LVEF 40% in the EU (10)
LEVERKUSEN, Germany, Jan. 31 -- Bayer, a pharmaceutical and life sciences company, issued the following news release on Jan. 30, 2026: * * * Finerenone recommended for the treatment of patients with heart failure with LVEF 40% in the EU CHMP adopts positive opinion for the marketing authorization of finerenone for patients with heart failure (HF) with left ventricular ejection fraction (LVEF) 40%, i.e. mildly reduced or preserved LVEF, in the European Union / The positive opinion is based on  more PR

Johnson & Johnson Receives CHMP Positive Opinion for Akeega for the Treatment of Patients With Metastatic Hormone-Sensitive Prostate Cancer With BRCA1/2 Mutations (10)
RARITAN, New Jersey, Jan. 31 -- Johnson and Johnson Innovative Medicine issued the following news release: * * * Johnson & Johnson receives CHMP positive opinion for AKEEGA(R) (niraparib and abiraterone acetate dual action tablet) for the treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC) with BRCA1/2 mutations AMPLITUDE is the first clinical trial to evaluate potential therapies for patients with mHSPC and known HRR gene alterations, with positive results support more PR

NFL and NBA leaders join Tulane's new Summer Sports Institute to train students for careers in sports (10)
NEW ORLEANS, Louisiana, Jan. 29 -- Tulane University issued the following news release: * * * NFL and NBA leaders join Tulane's new Summer Sports Institute to train students for careers in sports * Many college students dream of playing professional sports, but most careers in the industry happen off the field. And running a team or league involves decisions about venues, media, marketing, budgets and leadership, specific to professional sports, that students rarely obtain in a college class more PR